A new study published in the Proceedings of the National Academy of Sciences suggests that the structural diversity of bacteriophage (phage) tail fibers could help scientists predict which phages are capable of killing a wider range of bacterial strains. Researchers from McMaster University focused on Pseudomonas aeruginosa, a bacterium known for being resistant to many antibiotics, and examined how phages attach to it. They found that phages with more varied tail fibers were better at tolerating differences in the bacterial pili—thin, hair-like structures on the surface of bacteria that phages use to attach. In contrast, phages with similar tail fibers were more sensitive to even slight changes in pili structure, limiting their effectiveness against different strains. The study analyzed genetic data from over 1,300 unique P. aeruginosa strains and identified 53 distinct pili variants. These variations were concentrated in the regions of the pili that interact directly with phage tail fibers. The researchers suggest that bacteria may have evolved these different pili variants as a way to avoid being targeted by local phage populations. To test this, the team examined a group of phages, including two named after local roads—Cootes and Leland—and observed that some phages could infect bacteria with vastly different pili structures, while others could not. The findings indicate that the physical shape of a phage’s tail fiber might serve as a useful indicator of its ability to target a variety of bacterial strains. This could be a significant development for phage therapy, a treatment that uses phages to kill bacteria. Currently, identifying the right phage for a specific infection can take weeks, which is too slow for patients dealing with drug-resistant infections. If phage tail fiber diversity can be used to quickly identify broad-spectrum phages, it could help make phage therapy more practical and efficient in clinical settings. This research builds on earlier studies from the same laboratory, which have explored how bacteria evade phages and how phages can neutralize bacterial defenses. The goal is to improve the scalability and effectiveness of phage therapy, making it a more viable option for treating infections that are resistant to traditional antibiotics.